
For laboratory and qualified research professional use only.
Tesamorelin, a GHRH analogue, is an important tool in visceral adipose tissue research. This article outlines the mechanisms currently under investigation in Australian laboratory settings.
GHRH Receptor Studies
In pituitary and adipocyte models, tesamorelin stimulates the GHRH receptor, leading to increased growth-hormone release and downstream effects on lipid metabolism.
Adipose Tissue Models
Laboratory studies using human visceral fat explants have documented tesamorelin's ability to modulate lipolysis and reduce fat accumulation under controlled conditions.
Storage Guidelines
Proper laboratory storage at –20 °C for the lyophilised form and 2–8 °C for reconstituted solutions helps maintain peptide integrity across multiple experimental cycles.
For laboratory and qualified research professional use only.
→ Tesamorelin Research-Grade Peptide
→ Weight Loss Research Peptides
→ Tesamorelin Mechanism of Action
Related research articles
Research products mentioned
Important Notice: This article is for informational and educational purposes only. All products mentioned are exclusively for scientific research and are not intended for human consumption or therapeutic use.
